Back
Amprius Technologies Vs. Neurogene Industry Stock Comparison
Sell
46
AMPX
Amprius Technologies
Last Price:
1.20
Seasonality Move:
-8.63%
Buy
75
NGNE
Neurogene
Last Price:
65.96
Seasonality Move:
58.98%
Sell
46
Amprius Technologies (AMPX)
is a Sell
Is Amprius Technologies a Buy, Sell or Hold?
- The current Amprius Technologies [AMPX] share price is $1.19. The Score for AMPX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- AMPX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Neurogene (NGNE)
is a Buy
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $66.00. The Score for NGNE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NGNE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AMPX Stock Price Chart
What is Amprius Technologies's stock price today?
-
The Amprius Technologies share price today is $1.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMPX is experiencing selling pressure, which indicates risk of future bearish movement.
NGNE Stock Price Chart
AMPX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 44.68 | Sell |
| Chaikin Money Flow: | -1496405 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.16 - 1.48) | Sell |
| Bollinger Bands (100): | (0.99 - 1.35) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.06 | Buy |
| Relative Strength Index (14 RSI): | 75.97 | Buy |
| Chaikin Money Flow: | 176225 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.28 - 53.36) | Buy |
| Bollinger Bands (100): | (34.64 - 46.72) | Buy |
AMPX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.39 | Sell |
| 20-day SMA: | 1.37 | Sell |
| 50-day SMA: | 1.13 | Buy |
| 200-day SMA: | 1.87 | Sell |
| 8-day EMA: | 1.36 | Sell |
| 20-day EMA: | 1.33 | Sell |
| 50-day EMA: | 1.24 | Sell |
| 200-day EMA: | 2 | Sell |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.43 | Buy |
| 20-day SMA: | 49.56 | Buy |
| 50-day SMA: | 43.32 | Buy |
| 200-day SMA: | 37.93 | Buy |
| 8-day EMA: | 50.65 | Buy |
| 20-day EMA: | 48.54 | Buy |
| 50-day EMA: | 44.96 | Buy |
| 200-day EMA: | 36.96 | Buy |
Amprius Technologies Earnings Growth & AMPX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.09 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
Amprius Technologies Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||